Glofitamab,Obinutuzumab,Tocilizumab
roche
['2000', 'obinu', 'glofitamab', 'lymsm']
early data continue to suggest #glofitamab is highly effective in r/r mcl- exciting presentation by tycel philips - roughly 2/3 patients with prior btki achieve cr. #lymsm #ash2022 #ash22 
Clinical haematologist at Peter MacCallum Cancer Centre in Melbourne. Aggressive Lymphoma Lead. MDS/AML/myeloma.Early phase trials. Views are my own.